Community Pharmacist Utilization of Legislation That Allows Impact on the Opioid Crisis in the State of Minnesota: A Mixed-Methods Approach
- PMID: 30983492
- PMCID: PMC6848773
- DOI: 10.1177/0897190019841747
Community Pharmacist Utilization of Legislation That Allows Impact on the Opioid Crisis in the State of Minnesota: A Mixed-Methods Approach
Abstract
Background: As opioid overdose deaths climb, legislation supporting pharmacists in developing their role to address the crisis has expanded. Although Minnesota pharmacists are encouraged to utilize opiate antagonist, syringe access and authorized collector legislation, the use patterns of these tools are unknown.
Methods: A mixed-methods approach was used to survey 8405 Minnesota-licensed pharmacists on their practices related to the opioid crisis. An analysis of community pharmacist utilization of opioid-related legislation was conducted.
Results: The majority (88.64%) of respondents indicated that they had not dispensed naloxone in the past month using a protocol; 59.69% reported that they had not dispensed naloxone by any method in the past month. Over sixty percent (60.61%) of respondents agreed they are comfortable with dispensing syringes and would dispense noninsulin syringes in their pharmacy under the statewide Syringe Access Initiative; 25.86% reported that they are not comfortable dispensing syringes. The majority (78.64%) of respondents reported that they do not participate in collecting unwanted pharmaceuticals.
Conclusion: While pharmacists have the potential to play a key role in efforts focused on addressing the opioid crisis through harm reduction strategies, this role and the use of supporting legislation is currently underutilized in the state of Minnesota.
Keywords: naloxone; opioid; protocol; social and administrative sciences; syringe.
Conflict of interest statement
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Public Health and Pharmacy Partnerships in Opioid Harm Reduction: Responding to Community Needs.Prog Community Health Partnersh. 2021;15(1):37-46. doi: 10.1353/cpr.2021.0003. Prog Community Health Partnersh. 2021. PMID: 33775959
-
Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.J Urban Health. 2019 Jun;96(3):367-378. doi: 10.1007/s11524-019-00349-1. J Urban Health. 2019. PMID: 30747371 Free PMC article.
-
Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S55-S58.e3. doi: 10.1016/j.japh.2018.04.025. J Am Pharm Assoc (2003). 2018. PMID: 30006187
-
Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.Addict Sci Clin Pract. 2019 Sep 2;14(1):30. doi: 10.1186/s13722-019-0158-0. Addict Sci Clin Pract. 2019. PMID: 31474225 Free PMC article.
-
Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review.J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):178-194. doi: 10.1016/j.japh.2019.06.016. Epub 2019 Jul 29. J Am Pharm Assoc (2003). 2020. PMID: 31371179
Cited by
-
Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1555-1563.e2. doi: 10.1016/j.japh.2022.03.014. Epub 2022 Mar 19. J Am Pharm Assoc (2003). 2022. PMID: 35428578 Free PMC article.
-
The Role of the Pharmacist in Combating the Opioid Crisis: An Update.Subst Abuse Rehabil. 2022 Dec 28;13:127-138. doi: 10.2147/SAR.S351096. eCollection 2022. Subst Abuse Rehabil. 2022. PMID: 36597518 Free PMC article. Review.
-
Disadvantaged groups have greater spatial access to pharmacies in New York state.BMC Health Serv Res. 2024 Apr 15;24(1):471. doi: 10.1186/s12913-024-10901-8. BMC Health Serv Res. 2024. PMID: 38622604 Free PMC article.
References
-
- Rudd RA, Seth P, David F, et al. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep 2016;65(50–51):1445–1452. https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1.htm Accessed March 28, 2019 - PubMed
-
- Centers for Disease Control and Prevention. CDC WONDER. 2018. https://wonder.cdc.gov/ Accessed March 28, 2019.
-
- Minnesota Department of Health. Opioid Dashboard. 2019. http://www.health.state.mn.us/divs/healthimprovement/opioid-dashboard/#D... Accessed March 28, 2019.
-
- Bouillon T, Bruhn J, Roepcke H, et al. Opioid-induced respiratory depression is associated with increased tidal volume variability. Eur J Anaesthesiol. 2003;20(2):127–133. Accessed March 28, 2019. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous